• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, July 23, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Bioengineering & Translational Medicine honors biotech pioneers Langer and Peppas

Bioengineer by Bioengineer
January 18, 2019
in Biology
Reading Time: 3 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

January 2019 issue of fully gold open-access journal showcases advances in drug delivery and biomaterials inspired by the honorees

Hoboken, N.J–January 18, 2019–Bioengineering & Translational Medicine (BioTM), published by Wiley on behalf of the American Institute of Chemical Engineers (AIChE) and its Society for Biological Engineering (SBE), has released a tribute issue dedicated to research inspired by Robert Langer and Nicholas Peppas — two biotechnology luminaries whose game-changing contributions to drug delivery and biomaterials have made those fields integral elements of modern chemical engineering research and education.

Robert Langer, the David H. Koch Institute Professor at the Massachusetts Institute of Technology (MIT), established in his early career that proteins could be encapsulated in polymeric matrices and released in a sustained manner, and went on to invent many new biomedical technologies for drug delivery, as well as pioneering tissue engineering techniques for regenerative medicine. Nicholas Peppas, the Cockrell Family Regents Chaired Professor in Engineering, Medicine and Pharmacy at the University of Texas at Austin, established the quantitative principles for describing drug release from porous matrices and hydrogels, and his subsequent work in biomaterials and bionanotechnology has spawned many biomedical breakthroughs.

In a forward to the tribute issue, Aaron C. Anselmo, from the University of North Carolina at Chapel Hill, writes that the efforts of Langer and Peppas — individually and taken together — “have shaped the scholastic, academic, and technological landscape of drug delivery and biomaterials as we know them today.” Anselmo adds that Langer’s and Peppas’s pioneering research, along with their prominent leadership, “has advanced the visibility of drug delivery and biomaterials in the scientific landscape, especially within chemical engineering, and has inspired young professionals to follow their paths. The work featured in this issue provides a snapshot of the exciting work that has been inspired by them.”

Samir Mitragotri, Editor-in-Chief said, “It’s a privilege to honor Nicholas Peppas and Robert Langer in a special issue of BioTM. These two pioneers of drug delivery and biomaterials established the vision for the field, and brought it to the forefront through scholarly research, innovative technologies and inspirational mentorship to several generations of trainees.”

The January 2019 tribute issue of BioTM (Vol. 4, Issue 1) contains research articles from some of Langer’s and Peppas’s former students, as well as colleagues and admirers. The issue is freely available to read, download and share from Wiley Online Library at http://www.bioengtransmed.com.

Launched in 2015, BioTM journal focuses on the fundamental ways chemical and biological engineering approaches drive and provide innovative technologies and solutions that impact clinical practice and/or commercial healthcare products. Visit the journal website for more information.

###

Additional Information

Media Contacts

AIChE:

Gordon Ellis (US) +1 646-495-1348

[email protected]

Wiley:

Josh Glickman (US) +1 201-748-6572

[email protected]

Follow us on Twitter @WileyNews

About SBE

Established in 2004, the Society for Biological Engineering is a technological community for engineers and applied scientists integrating biology with engineering. Members of SBE come from a broad spectrum of industries and disciplines and share in SBE’s mission of realizing the benefits of bioprocessing, biomedical and biomolecular applications. http://bio.aiche.org.

About AIChE

AIChE is a professional society of more than 60,000 chemical engineers in 110 countries. Its members work in corporations, universities and government using their knowledge of chemical processes to develop safe and useful products for the benefit of society. Through its varied programs, AIChE continues to be a focal point for information exchange on the frontiers of chemical engineering research in such areas as energy, sustainability, biological and environmental engineering, nanotechnology and chemical plant safety and security. More information about AIChE is available at http://www.aiche.org.

About Wiley

Wiley is a global leader in research and education. Our online scientific, technical, medical, and scholarly journals, and our digital learning, assessment, certification and student-lifecycle services and solutions help universities, academic societies, businesses, governments and individuals to achieve their academic and professional goals. For more than 200 years, we have delivered consistent performance to our stakeholders. The Company’s website can be accessed at http://www.wiley.com.

Media Contact
Josh Glickman
[email protected]
201-748-6000
https://newsroom.wiley.com/press-release/all-corporate-news/bioengineering-translational-medicine-honors-biotech-pioneers-rober

Tags: Biomedical/Environmental/Chemical EngineeringBiotechnologyTechnology/Engineering/Computer Science
Share12Tweet8Share2ShareShareShare2

Related Posts

Machine Learning Uncovers Sorghum’s Complex Mold Resistance

July 20, 2025
blank

Archaeal Ribosome Shows Unique Active Site, Hibernation Factor

July 17, 2025

Mobile Gene Regulator Balances Arabidopsis Shoot-Root Growth

July 16, 2025

Mobile Transcription Factor Drives Nitrogen Deficiency Response

July 16, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    59 shares
    Share 24 Tweet 15
  • New Organic Photoredox Catalysis System Boosts Efficiency, Drawing Inspiration from Photosynthesis

    54 shares
    Share 22 Tweet 14
  • IIT Researchers Unveil Flying Humanoid Robot: A Breakthrough in Robotics

    53 shares
    Share 21 Tweet 13
  • AI Achieves Breakthrough in Drug Discovery by Tackling the True Complexity of Aging

    70 shares
    Share 28 Tweet 18

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Additive Manufacturing of Monolithic Gyroidal Solid Oxide Cells

Machine Learning Uncovers Sorghum’s Complex Mold Resistance

Pathology Multiplexing Revolutionizes Disease Mapping

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.